TABLE 1.
Morphological malformations in zebrafish embryos at 96 hpf.
| Concentration (µg/ml) | Morphological abnormalities (%) | ||
| Pericardial oedema | Yolk oedema | Spinal curvature | |
| Negative Control | 0 | 0 | 0 |
| Solvent Control | 0 | 0 | 0 |
| Positive control | 100 ± 0.00 | 100 ± 0.00 | 67.18 ± 20.59 |
| Kratom decoction | |||
| 31.25 | 0 | 0 | 0 |
| 62.5 | 0 | 0 | 0 |
| 125 | 0 | 0 | 0 |
| 250 | 0 | 0 | 0 |
| 500 | a | a | a |
| 1000 | a | a | a |
| Mitragynine | |||
| 3.125 | 0 | 0 | 0 |
| 6.25 | 0 | 0 | 0 |
| 12.5 | 0 | 0 | 0 |
| 25 | 0 | 0 | 3.92 ± 3.40 |
| 50 | 0 | 0 | 7.34 ± 2.80** |
| 100 | a | a | a |
| Speciociliatine | |||
| 3.125 | 0 | 0 | 0 |
| 6.25 | 0 | 0 | 0 |
| 12.5 | 0 | 0 | 0 |
| 25 | 0 | 0 | 12.48 ± 2.88*** |
| 50 | 0 | 0 | 25.05 ± 3.54*** |
| 100 | a | a | a |
| Morphine | |||
| 3.125 | 5.36 ± 0.17 | 1.75 ± 3.04 | 5.26 ± 5.26 |
| 6.25 | 7.02 ± 3.04* | 3.51 ± 3.04 | 5.46 ± 5.56 |
| 12.5 | 7.21 ± 3.38* | 3.61 ± 3.13 | 5.36 ± 0.17 |
| 25 | 7.42 ± 3.21* | 3.81 ± 3.31 | 7.42 ± 3.21 |
| 50 | 9.26 ± 3.21** | 5.56 ± 1.09 | 7.41 ± 3.21 |
| 100 | 9.06 ± 3.05** | 7.21 ± 2.87* | 9.16 ± 3.38* |
Data are expressed as the mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 significantly different from the negative control group.
indicate not determined.